244 related articles for article (PubMed ID: 3732523)
21. Performance of the Dalkon Shield intrauterine device.
Jones RW
N Z Med J; 1975 Aug; 82(545):85-7. PubMed ID: 1058347
[TBL] [Abstract][Full Text] [Related]
22. Options for intrauterine contraception.
Fantasia HC
J Obstet Gynecol Neonatal Nurs; 2008; 37(3):375-83. PubMed ID: 18507611
[TBL] [Abstract][Full Text] [Related]
23. IUDs--an update.
Popul Rep B; 1995 Dec; (6):1-35. PubMed ID: 8724322
[TBL] [Abstract][Full Text] [Related]
24. The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond?
Chi IC
Contraception; 1993 Apr; 47(4):325-47. PubMed ID: 8508663
[TBL] [Abstract][Full Text] [Related]
25. The misplaced or missing IUD.
Gentile GP; Siegler AM
Obstet Gynecol Surv; 1977 Oct; 32(10):627-41. PubMed ID: 331162
[No Abstract] [Full Text] [Related]
26. [Intrauterine devices].
Delavest P; Engelmann P
Rev Prat; 1980 Dec; 30(57):3981-2, 3985-7. PubMed ID: 7455547
[TBL] [Abstract][Full Text] [Related]
27. Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study.
Gatz JL; Armstrong MA; Postlethwaite D; Raine-Bennett T; Chillemi G; Alabaster A; Merchant M; Reed SD; Ichikawa L; Getahun D; Fassett MJ; Shi JM; Xie F; Chiu VY; Im TM; Takhar HS; Wang J; Saltus CW; Ritchey ME; Asiimwe A; Pisa F; Schoendorf J; Wahdan Y; Zhou X; Hunter S; Anthony MS; Peipert JF
Am J Obstet Gynecol; 2022 Jul; 227(1):57.e1-57.e13. PubMed ID: 35395215
[TBL] [Abstract][Full Text] [Related]
28. Risks of intrauterine contraceptive devices.
Siddle N
Br Med J (Clin Res Ed); 1984 May; 288(6430):1554-5. PubMed ID: 6426640
[No Abstract] [Full Text] [Related]
29. [Intrauterine contraception with bioactive devices. Clinico-statistical experience with a copper-potentiated IUD (Gravigard)].
Foti A; Carluccio A
Minerva Ginecol; 1979 Sep; 31(9):629-38. PubMed ID: 395462
[No Abstract] [Full Text] [Related]
30. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.
Lyus R; Lohr P; Prager S;
Contraception; 2010 May; 81(5):367-71. PubMed ID: 20399942
[TBL] [Abstract][Full Text] [Related]
31. Intrauterine devices: mechanisms of action, safety, and efficacy.
Mishell DR
Contraception; 1998 Sep; 58(3 Suppl):45S-53S; quiz 70S. PubMed ID: 9807692
[No Abstract] [Full Text] [Related]
32. [Reasons for removal of intrauterine devices among women in general practice].
Kolding L; Majeed HG
Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897
[TBL] [Abstract][Full Text] [Related]
33. Clinical aspects of intrauterine contraception: circumspection 1976.
Tatum HJ
Fertil Steril; 1977 Jan; 28(1):3-28. PubMed ID: 319019
[No Abstract] [Full Text] [Related]
34. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings.
Steen R; Shapiro K
Reprod Health Matters; 2004 May; 12(23):136-43. PubMed ID: 15242222
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and therapeutic technology assessment. Intrauterine devices.
JAMA; 1989 Apr; 261(14):2127-30. PubMed ID: 2926948
[TBL] [Abstract][Full Text] [Related]
36. [Proceedings: Use of intrauterine pessaries].
Haspels AA
Arch Gynakol; 1973 Sep; 214(1):464-79. PubMed ID: 4801523
[No Abstract] [Full Text] [Related]
37. [Modern intra-uterine contraception: a better option].
Hamerlynck JV; Knuist M
Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1621-4. PubMed ID: 11552362
[TBL] [Abstract][Full Text] [Related]
38. Association between menorrhagia and risk of intrauterine device-related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device study.
Getahun D; Fassett MJ; Gatz J; Armstrong MA; Peipert JF; Raine-Bennett T; Reed SD; Zhou X; Schoendorf J; Postlethwaite D; Shi JM; Saltus CW; Wang J; Xie F; Chiu VY; Merchant M; Alabaster A; Ichikawa LE; Hunter S; Im TM; Takhar HS; Ritchey ME; Chillemi G; Pisa F; Asiimwe A; Anthony MS
Am J Obstet Gynecol; 2022 Jul; 227(1):59.e1-59.e9. PubMed ID: 35292234
[TBL] [Abstract][Full Text] [Related]
39. Comparative randomized study of the copper-T 200 and Dalkon Shield intrauterine devices.
Spellacy WN; Birk SA; Gordon L
Contraception; 1975 Oct; 12(4):453-63. PubMed ID: 1192734
[TBL] [Abstract][Full Text] [Related]
40. The GyneFix implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception. International Study Group on Intrauterine Drug Delivery.
Van Kets H; Van der Pas H; Thiery M; Wildemeersch D; Vrijens M; Van Trappen Y; Temmerman M; DePypere H; Delbarge W; Dhont M; Defoort P; Schacht EH; Bàtàr I; Barri P; Martinez F; Iglesias Cortit LH; Creatsas G; Shangchun W; Xiaoming C; Zuan-chong F; Yu-ming W; Andrade A; Reinprayoon D; Pizarro E
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):1-13. PubMed ID: 9678104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
